Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;26(4):187-192.
doi: 10.1136/ejhpharm-2018-001725. Epub 2018 Nov 16.

Medication adherence interventions and outcomes: an overview of systematic reviews

Affiliations

Medication adherence interventions and outcomes: an overview of systematic reviews

Nina C Wilhelmsen et al. Eur J Hosp Pharm. 2019 Jul.

Abstract

Objective: To present evidence for healthcare-provided medication adherence interventions on clinical, economic and humanistic outcomes among patients.

Methods: Literature search of systematic reviews in Medline, Embase and CINAHL (2007-2017), validation of quality using A Measurement Tool to Assess Systematic Reviews (AMSTAR) 2 and Preferred Reporting Items for Systematic Reviews and Meta-Analyses questionnaires and, finally, extraction, combination and tabulation of results for included studies.

Results: From eight systematic reviews with medium to high AMSTAR 2 score, 37 randomised controlled studies involving 28 600 participants were extracted. Patient education and counselling showed some positive effects on medication adherence. Patient education also showed some positive effects on morbidity, healthcare utilities and patient satisfaction. Counselling had some benefit on mortality and healthcare utilisation. Simplifying doses was shown to have some benefit on morbidity and patient satisfaction. Interventions delivered by pharmacists and nurses showed a better result in improving adherence and outcomes than interventions delivered by general practitioners.

Conclusions: Some interventions were found to have positive effect on adherence and outcomes, but no single strategy showed improvement in all settings. For future research patients should be screened for non-adherence to reveal both if they are non-adherent and type of non-adherence, as well as bigger sample sizes and longer duration of follow-up.

Keywords: adherence; intervention; medication; outcomes; review.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow diagram of studies found, assessed, excluded and included. AMSTAR, A Measurement Tool to Assess Systematic Reviews; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.

References

    1. Mulrow CD. Systematic Reviews: Rationale for systematic reviews. BMJ 1994;309:597–9. 10.1136/bmj.309.6954.597 - DOI - PMC - PubMed
    1. Sackett DL, Rosenberg WM, Gray JA, et al. . Evidence based medicine: what it is and what it isn’t. BMJ 1996;312:71–2. 10.1136/bmj.312.7023.71 - DOI - PMC - PubMed
    1. Wiffen P, Eriksson T, Lu H. CHAPTER 2 introduction to evidence-based practice in evidence-based pharmacy 2nd edition. Eur J Hosp Pharm 2013;20:324–7. 10.1136/ejhpharm-2013-000415 - DOI
    1. Eriksson T, Lu H, Wiffen P. Chapter 6: How to best practice evidence-based pharmacy with your available resources? Eur J Hosp Pharm 2014;21:194–201. 10.1136/ejhpharm-2014-000497 - DOI
    1. Wiffen P, Eriksson T, Lu H. CHAPTER 3: Asking and formulating the right questions and finding useful resources in evidence-based pharmacy—2nd edition. Eur J Hosp Pharm Sci 2014;21:2–6. 10.1136/ejhpharm-2013-000428 - DOI

Publication types